SHINE facility to produce ingredient in targeted cancer treatments
Janesville-based SHINE Technologies said last week that it’s opening the largest facility in North America dedicated to producing an ingredient for targeted cancer therapies.
To access this content, you must purchase a Premium membership, or log in if you are a member.
